{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:38:27Z","timestamp":1787002707244,"version":"build-2736575974"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000053","name":"U.S. Department of Health & Human Services | NIH | National Eye Institute","doi-asserted-by":"publisher","award":["RO1 EY029709"],"award-info":[{"award-number":["RO1 EY029709"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Human interleukin-33 (IL-33) is a 270 amino acid protein that belongs to the IL-1 cytokine family and plays an important role in various inflammatory disorders. Neutrophil proteases (Cathepsin G and Elastase) and mast cell proteases (tryptase and chymase) regulate the activity of IL-33 by processing full-length IL-33 into its mature form. There is little evidence on the role of these mature forms of IL-33 in retinal endothelial cell signaling and pathological retinal angiogenesis. Here, we cloned, expressed, and purified the various mature forms of human IL-33 and then evaluated the effects of IL-33\n                    <jats:sub>95-270<\/jats:sub>\n                    , IL-33\n                    <jats:sub>99-270<\/jats:sub>\n                    , IL-33\n                    <jats:sub>109-270<\/jats:sub>\n                    , and IL-33\n                    <jats:sub>112-270<\/jats:sub>\n                    on angiogenesis in human retinal microvascular endothelial cells (HRMVECs). We observed that IL-33\n                    <jats:sub>95-270<\/jats:sub>\n                    , IL-33\n                    <jats:sub>99-270<\/jats:sub>\n                    , IL-33\n                    <jats:sub>109-270<\/jats:sub>\n                    , and IL-33\n                    <jats:sub>112-270<\/jats:sub>\n                    significantly induced HRMVEC migration, tube formation and sprouting angiogenesis. However, only IL-33\n                    <jats:sub>99-270<\/jats:sub>\n                    could induce HRMVEC proliferation. We used a murine model of oxygen-induced retinopathy (OIR) to assess the role of these mature forms of IL-33 in pathological retinal neovascularization. Our 3\u2032-mRNA sequencing and signaling studies indicated that IL-33\n                    <jats:sub>99-270<\/jats:sub>\n                    and IL-33\n                    <jats:sub>109-270<\/jats:sub>\n                    were more potent at inducing endothelial cell activation and angiogenesis than the other mature forms. We found that genetic deletion of IL-33 significantly reduced OIR-induced retinal neovascularization in the mouse retina and that intraperitoneal administration of mature forms of IL-33, mainly IL-33\n                    <jats:sub>99\u2013270<\/jats:sub>\n                    and IL-33\n                    <jats:sub>109\u2013270<\/jats:sub>\n                    , significantly restored ischemia-induced angiogenic sprouting and tuft formation in the hypoxic retinas of IL-33\n                    <jats:sup>\u2013\/\u2013<\/jats:sup>\n                    mice. Thus, our study results suggest that blockade or inhibition of IL-33 cleavage by neutrophil proteases could help mitigate pathological angiogenesis in proliferative retinopathies.\n                  <\/jats:p>","DOI":"10.1038\/s12276-024-01279-y","type":"journal-article","created":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T21:10:43Z","timestamp":1722460243000},"page":"1703-1716","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["A neutrophil elastase-generated mature form of IL-33 is a potent regulator of endothelial cell activation and proliferative retinopathy"],"prefix":"10.1038","volume":"56","author":[{"given":"Shivantika","family":"Bisen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shailendra Kumar","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandra Sekhar","family":"Mukhopadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3665-6023","authenticated-orcid":false,"given":"Nikhlesh K.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,1]]},"reference":[{"key":"1279_CR1","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.immuni.2013.11.010","volume":"39","author":"C Garlanda","year":"2013","unstructured":"Garlanda, C., Dinarello, C. A. & Mantovani, A. The interleukin-1 family: back to the future. Immunity 39, 1003\u20131018 (2013).","journal-title":"Immunity"},{"key":"1279_CR2","doi-asserted-by":"crossref","first-page":"9021","DOI":"10.1073\/pnas.0812690106","volume":"106","author":"C Cayrol","year":"2009","unstructured":"Cayrol, C. & Girard, J. P. The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1. Proc. Natl Acad. Sci. USA 106, 9021\u20139026 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1279_CR3","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.immuni.2005.09.015","volume":"23","author":"J Schmitz","year":"2005","unstructured":"Schmitz, J. et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23, 479\u2013490 (2005).","journal-title":"Immunity"},{"key":"1279_CR4","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nri2692","volume":"10","author":"FY Liew","year":"2010","unstructured":"Liew, F. Y., Pitman, N. I. & McInnes, I. B. Disease-associated functions of IL-33: the new kid in the IL-1 family. Nat. Rev. Immunol. 10, 103\u2013110 (2010).","journal-title":"Nat. Rev. Immunol."},{"key":"1279_CR5","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1182\/blood-2009-02-203372","volume":"114","author":"YS Choi","year":"2009","unstructured":"Choi, Y. S. et al. Interleukin-33 induces angiogenesis and vascular permeability through ST2\/TRAF6-mediated endothelial nitric oxide production. Blood 114, 3117\u20133126 (2009).","journal-title":"Blood"},{"key":"1279_CR6","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/s42003-022-03432-7","volume":"5","author":"D Sharma","year":"2022","unstructured":"Sharma, D. et al. IL-33 enhances Jagged1 mediated NOTCH1 intracellular domain (NICD) deubiquitination and pathological angiogenesis in proliferative retinopathy. Commun. Biol. 5, 479 (2022).","journal-title":"Commun. Biol."},{"key":"1279_CR7","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/s42003-023-04905-z","volume":"6","author":"G Kaur","year":"2023","unstructured":"Kaur, G. et al. Vascular cell-adhesion molecule 1 (VCAM-1) regulates JunB-mediated IL-8\/CXCL1 expression and pathological neovascularization. Commun. Biol. 6, 516 (2023).","journal-title":"Commun. Biol."},{"key":"1279_CR8","doi-asserted-by":"crossref","first-page":"703","DOI":"10.3390\/cells12050703","volume":"12","author":"D Sharma","year":"2023","unstructured":"Sharma, D. et al. IL-33 via PKC\u03bc\/PRKD1 mediated \u03b1-catenin phosphorylation regulates endothelial cell-barrier integrity and ischemia-induced vascular leakage. Cells 12, 703 (2023).","journal-title":"Cells"},{"key":"1279_CR9","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/imm.12589","volume":"148","author":"S Shan","year":"2016","unstructured":"Shan, S. et al. Nasal administration of interleukin-33 induces airways angiogenesis and expression of multiple angiogenic factors in a murine asthma surrogate. Immunology 148, 83\u201391 (2016).","journal-title":"Immunology"},{"key":"1279_CR10","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.molimm.2017.06.249","volume":"90","author":"R He","year":"2017","unstructured":"He, R. et al. IL-33 improves wound healing through enhanced M2 macrophage polarization in diabetic mice. Mol. Immunol. 90, 42\u201349 (2017).","journal-title":"Mol. Immunol."},{"key":"1279_CR11","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ebiom.2018.06.003","volume":"33","author":"J Liu","year":"2018","unstructured":"Liu, J. et al. IL-33 initiates vascular remodelling in hypoxic pulmonary hypertension by up-regulating HIF-1\u03b1 and VEGF expression in vascular endothelial cells. EBioMedicine 33, 196\u2013210 (2018).","journal-title":"EBioMedicine"},{"key":"1279_CR12","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/path.4816","volume":"241","author":"S Theodoropoulou","year":"2017","unstructured":"Theodoropoulou, S. et al. Interleukin-33 regulates tissue remodelling and inhibits angiogenesis in the eye. J. Pathol. 241, 45\u201356 (2017).","journal-title":"J. Pathol."},{"key":"1279_CR13","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0002-9440(10)63631-0","volume":"163","author":"ES Baekkevold","year":"2003","unstructured":"Baekkevold, E. S. et al. Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules. Am. J. Pathol. 163, 69\u201379 (2003).","journal-title":"Am. J. Pathol."},{"key":"1279_CR14","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1073\/pnas.0606854104","volume":"104","author":"V Carriere","year":"2007","unstructured":"Carriere, V. et al. IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo. Proc. Natl Acad. Sci. USA 104, 282\u2013287 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1279_CR15","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/embor.2008.145","volume":"9","author":"L Roussel","year":"2008","unstructured":"Roussel, L., Erard, M., Cayrol, C. & Girard, J. P. Molecular mimicry between IL-33 and KSHV for attachment to chromatin through the H2A-H2B acidic pocket. EMBO Rep. 9, 1006\u20131012 (2008).","journal-title":"EMBO Rep."},{"key":"1279_CR16","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.immuni.2009.05.007","volume":"31","author":"AU Luthi","year":"2009","unstructured":"Luthi, A. U. et al. Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases. Immunity 31, 84\u201398 (2009).","journal-title":"Immunity"},{"key":"1279_CR17","doi-asserted-by":"crossref","first-page":"19420","DOI":"10.1074\/jbc.M901744200","volume":"284","author":"D Talabot-Ayer","year":"2009","unstructured":"Talabot-Ayer, D., Lamacchia, C., Gabay, C. & Palmer, G. Interleukin-33 is biologically active independently of caspase-1 cleavage. J. Biol. Chem. 284, 19420\u201319426 (2009).","journal-title":"J. Biol. Chem."},{"key":"1279_CR18","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/j.bbrc.2009.12.107","volume":"391","author":"S Ali","year":"2010","unstructured":"Ali, S., Nguyen, D. Q., Falk, W. & Martin, M. U. Caspase 3 inactivates biologically active full-length interleukin-33 as a classical cytokine but does not prohibit nuclear translocation. Biochem. Biophys. Res. Commun. 391, 1512\u20131516 (2010).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1279_CR19","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1073\/pnas.1115884109","volume":"109","author":"E Lefran\u00e7ais","year":"2012","unstructured":"Lefran\u00e7ais, E. et al. IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G. Proc. Natl Acad. Sci. USA 109, 1673\u20131678 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1279_CR20","doi-asserted-by":"crossref","first-page":"15502","DOI":"10.1073\/pnas.1410700111","volume":"111","author":"E Lefran\u00e7ais","year":"2014","unstructured":"Lefran\u00e7ais, E. et al. Central domain of IL-33 is cleaved by mast cell proteases for potent activation of group-2 innate lymphoid cells. Proc. Natl Acad. Sci. USA 111, 15502\u201315507 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1279_CR21","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1600-065X.2008.00624.x","volume":"223","author":"WP Arend","year":"2008","unstructured":"Arend, W. P., Palmer, G. & Gabay, C. IL-1, IL-18, and IL-33 families of cytokines. Immunol. Rev. 223, 20\u201338 (2008).","journal-title":"Immunol. Rev."},{"key":"1279_CR22","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1172\/JCI30634","volume":"117","author":"S Sanada","year":"2007","unstructured":"Sanada, S. et al. IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system. J. Clin. Invest. 117, 1538\u20131549 (2007).","journal-title":"J. Clin. Invest."},{"key":"1279_CR23","doi-asserted-by":"crossref","first-page":"e0226701","DOI":"10.1371\/journal.pone.0226701","volume":"15","author":"CL Hsu","year":"2020","unstructured":"Hsu, C. L. et al. Allergic inflammation is initiated by IL-33-dependent crosstalk between mast cells and basophils. PLoS ONE 15, e0226701 (2020).","journal-title":"PLoS ONE"},{"key":"1279_CR24","doi-asserted-by":"crossref","first-page":"5860","DOI":"10.1073\/pnas.93.12.5860","volume":"93","author":"M Lakso","year":"1996","unstructured":"Lakso, M. et al. Efficient in vivo manipulation of mouse genomic sequences at the zygote stage. Proc. Natl Acad. Sci. USA 93, 5860\u20135865 (1996).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1279_CR25","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/j.ebiom.2015.09.042","volume":"2","author":"NK Singh","year":"2015","unstructured":"Singh, N. K., Kotla, S., Kumar, R. & Rao, G. N. Cyclic AMP response element binding protein mediates pathological retinal neovascularization via modulating DLL4-NOTCH1 signaling. EBioMedicine 2, 1767\u20131784 (2015).","journal-title":"EBioMedicine"},{"key":"1279_CR26","first-page":"e22440","volume":"36","author":"B Roy","year":"2022","unstructured":"Roy, B., Pan, G., Giri, S., Thandavarayan, R. A. & Palaniyandi, S. S. Aldehyde dehydrogenase 2 augments adiponectin signaling in coronary angiogenesis in HFpEF associated with diabetes. FASEB J. 36, e22440 (2022).","journal-title":"FASEB J."},{"key":"1279_CR27","first-page":"101","volume":"35","author":"LE Smith","year":"1994","unstructured":"Smith, L. E. et al. Oxygen-induced retinopathy in the mouse. Invest. Ophthalmol. Vis. Sci. 35, 101\u2013111 (1994).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"1279_CR28","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1038\/nprot.2009.187","volume":"4","author":"KM Connor","year":"2009","unstructured":"Connor, K. M. et al. Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis. Nat. Protoc. 4, 1565\u20131573 (2009).","journal-title":"Nat. Protoc."},{"key":"1279_CR29","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder, P. & Horvath, S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics 9, 559 (2008).","journal-title":"BMC Bioinformatics"},{"key":"1279_CR30","unstructured":"Johnstone, T. Heatmaps for gene expression. https:\/\/rpubs.com\/tgjohnst\/heatmaps_testing_1 (2015)."},{"key":"1279_CR31","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1128\/MMBR.00031-10","volume":"75","author":"M Cargnello","year":"2011","unstructured":"Cargnello, M. & Roux, P. P. Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases. Microbiol. Mol. Biol. Rev. 75, 50\u201383 (2011).","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"1279_CR32","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1177\/1947601911423030","volume":"2","author":"NM Kofler","year":"2011","unstructured":"Kofler, N. M. et al. Notch signaling in developmental and tumor angiogenesis. Genes Cancer 2, 1106\u20131116 (2011).","journal-title":"Genes Cancer"},{"key":"1279_CR33","first-page":"a005058","volume":"3","author":"P Lu","year":"2011","unstructured":"Lu, P., Takai, K., Weaver, V. M. & Werb, Z. Extracellular matrix degradation and remodeling in development and disease. Cold Spring Harb. Perspect. Biol. 3, a005058 (2011).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"1279_CR34","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/112_2021_67","volume":"184","author":"D Sharma","year":"2023","unstructured":"Sharma, D. & Singh, N. K. The biochemistry and physiology of a disintegrin and metalloproteinases (ADAMs and ADAM-TSs) in human pathologies. Rev. Physiol. Biochem. Pharmacol. 184, 69\u2013120 (2023).","journal-title":"Rev. Physiol. Biochem. Pharmacol."},{"key":"1279_CR35","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.ajhg.2009.09.011","volume":"85","author":"J Morales","year":"2009","unstructured":"Morales, J. et al. Homozygous mutations in ADAMTS10 and ADAMTS17 cause lenticular myopia, ectopia lentis, glaucoma, spherophakia, and short stature. Am. J. Hum. Genet. 85, 558\u2013568 (2009).","journal-title":"Am. J. Hum. Genet."},{"key":"1279_CR36","first-page":"1114","volume":"14","author":"M Ber\u00e1nek","year":"2008","unstructured":"Ber\u00e1nek, M., Kolar, P., Tschoplova, S., Kankova, K. & Vasku, A. Genetic variations and plasma levels of gelatinase A (matrix metalloproteinase-2) and gelatinase B (matrix metalloproteinase-9) in proliferative diabetic retinopathy. Mol. Vis. 14, 1114\u20131121 (2008).","journal-title":"Mol. Vis."},{"key":"1279_CR37","doi-asserted-by":"crossref","first-page":"e3331","DOI":"10.1371\/journal.pone.0003331","volume":"3","author":"C Moussion","year":"2008","unstructured":"Moussion, C., Ortega, N. & Girard, J. P. The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel \u2018alarmin\u2019? PLoS ONE 3, e3331 (2008).","journal-title":"PLoS ONE"},{"key":"1279_CR38","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.immuni.2009.06.011","volume":"31","author":"M Lamkanfi","year":"2009","unstructured":"Lamkanfi, M. & Dixit, V. M. IL-33 raises alarm. Immunity 31, 5\u20137 (2009).","journal-title":"Immunity"},{"key":"1279_CR39","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41590-018-0067-5","volume":"19","author":"C Cayrol","year":"2018","unstructured":"Cayrol, C. et al. Environmental allergens induce allergic inflammation through proteolytic maturation of IL-33. Nat. Immunol. 19, 375\u2013385 (2018).","journal-title":"Nat. Immunol."},{"key":"1279_CR40","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/imr.12619","volume":"281","author":"C Cayrol","year":"2018","unstructured":"Cayrol, C. & Girard, J. P. Interleukin-33 (IL-33): a nuclear cytokine from the IL-1 family. Immunol. Rev. 281, 154\u2013168 (2018).","journal-title":"Immunol. Rev."},{"key":"1279_CR41","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/nm1603","volume":"13","author":"CJ Chen","year":"2007","unstructured":"Chen, C. J. et al. Identification of a key pathway required for the sterile inflammatory response triggered by dying cells. Nat. Med. 13, 851\u2013856 (2007).","journal-title":"Nat. Med."},{"key":"1279_CR42","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1136\/ard.2009.122655","volume":"69","author":"WA Verri Jr","year":"2010","unstructured":"Verri, W. A. Jr et al. IL-33 induces neutrophil migration in rheumatoid arthritis and is a target of anti-TNF therapy. Ann. Rheum. Dis. 69, 1697\u20131703 (2010).","journal-title":"Ann. Rheum. Dis."},{"key":"1279_CR43","doi-asserted-by":"crossref","first-page":"10913","DOI":"10.1073\/pnas.0801898105","volume":"105","author":"D Xu","year":"2008","unstructured":"Xu, D. et al. IL-33 exacerbates antigen-induced arthritis by activating mast cells. Proc. Natl Acad. Sci. USA 105, 10913\u201310918 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1279_CR44","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/art.24305","volume":"60","author":"G Palmer","year":"2009","unstructured":"Palmer, G. et al. Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis. Arthritis Rheum. 60, 738\u2013749 (2009).","journal-title":"Arthritis Rheum."},{"key":"1279_CR45","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nri.2016.95","volume":"16","author":"FY Liew","year":"2016","unstructured":"Liew, F. Y., Girard, J. P. & Turnquist, H. R. Interleukin-33 in health and disease. Nat. Rev. Immunol. 16, 676\u2013689 (2016).","journal-title":"Nat. Rev. Immunol."},{"key":"1279_CR46","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/j.cellsig.2008.05.013","volume":"20","author":"M Funakoshi-Tago","year":"2008","unstructured":"Funakoshi-Tago, M. et al. TRAF6 is a critical signal transducer in IL-33 signaling pathway. Cell Signal. 20, 1679\u20131686 (2008).","journal-title":"Cell Signal."},{"key":"1279_CR47","doi-asserted-by":"crossref","first-page":"18660","DOI":"10.1073\/pnas.0705939104","volume":"104","author":"S Ali","year":"2007","unstructured":"Ali, S. et al. IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells. Proc. Natl Acad. Sci. USA 104, 18660\u201318665 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1279_CR48","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.4049\/jimmunol.179.4.2551","volume":"179","author":"AA Chackerian","year":"2007","unstructured":"Chackerian, A. A. et al. IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex. J. Immunol. 179, 2551\u20132555 (2007).","journal-title":"J. Immunol."},{"key":"1279_CR49","volume":"15","author":"K Cao","year":"2018","unstructured":"Cao, K. et al. IL-33\/ST2 plays a critical role in endothelial cell activation and microglia-mediated neuroinflammation modulation. J. Neuroinflammation 15, 136 (2018).","journal-title":"J. Neuroinflammation"}],"container-title":["Experimental &amp; Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s12276-024-01279-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-024-01279-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-024-01279-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T03:04:11Z","timestamp":1725332651000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s12276-024-01279-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,1]]},"references-count":49,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["1279"],"URL":"https:\/\/doi.org\/10.1038\/s12276-024-01279-y","relation":{},"ISSN":["2092-6413"],"issn-type":[{"value":"2092-6413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,1]]},"assertion":[{"value":"3 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}